ScholarIQanswers from OpenAlex
Gdańsk Medical University
InstitutionResearch output, impact & collaborations
Gdańsk Medical University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Gdańsk Medical University?
ScholarIQrecord summary
Gdańsk Medical University is a research organisation in Gdansk, PL. OpenAlex records 28,498 works and 1,306,969 citations for it. 6,469 researchers list it as their most recent affiliation.
How many works does Gdańsk Medical University have?
ScholarIQindexed works
Gdańsk Medical University has 28,498 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gdańsk Medical University have?
ScholarIQcitation count
Gdańsk Medical University has 1,306,969 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Gdańsk Medical University?
ScholarIQresearcher count
Gdańsk Medical University has 6,469 researchers in the ScholarIQ index.
What is the average h-index at Gdańsk Medical University?
ScholarIQavg h-index
Gdańsk Medical University has an average h-index of 45 in OpenAlex.
What is the ROR of Gdańsk Medical University?
ScholarIQror
The ROR for Gdańsk Medical University is on the source record.
What is the OpenAlex record for Gdańsk Medical University?
ScholarIQopenalex
The OpenAlex for Gdańsk Medical University is on the source record.
What is the Wikidata of Gdańsk Medical University?
ScholarIQwikidata
The Wikidata for Gdańsk Medical University is on the source record.
Who are the most-cited researchers behind Gdańsk Medical University?
ScholarIQtop researchers by citations
What are the most-cited papers on Gdańsk Medical University?
ScholarIQmost cited works
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, T. Delozier, Stephen E. Jones, Isabel Álvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley Fallowfield, E. Mickiewicz, Jørn Andersen, Per Eystein Lønning, Giorgio Cocconi, Alan L. Stewart, Nick Stuart, Claire Snowdon, M. Carpentieri, Giorgio Massimini, Judith M. Bliss
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andrić, Sarayut Lucien Geater, Mustafa Özgüroğlu, Wei Zou, Alan Sandler, Ida Enquist, Kimberly M. Komatsubara, Yu Deng, Hiroshi Kuriki, Xiaohui Wen, Mark L. McCleland, Simonetta Mocci, Jacek Jassem, David R. Spigel
Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer
Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti‐Rosei, Ettore Ambrosioni, Michel Burnier, Mark J. Caulfield, Renata Cífková, Denis Clément, António Coca, Anna F. Dominiczak, Serap Erdine, Robert Fagard, Csaba Farsang, Guıdo Grassı, Hermann Haller, Anthony M. Heagerty, Sverre E. Kjeldsen, Wolfgang Kiowski, Jean Mallion, Athanasios Manolis, Krzysztof Narkiewicz, Peter M. Nilsson, Michael Hecht Olsen, K. H. Rahn, Josep Redón, José L. Rodicio, Luís M. Ruilope, Roland E. Schmieder, Harry A.J. Struijker-Boudier, Pieter A. van Zwieten, Margus Viigimaa, Alberto Zanchetti
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Fátima Cardoso, Shani Paluch–Shimon, Elżbieta Senkus, Giuseppe Curigliano, Matti Aapro, Fabrice André, C.H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Frances Boyle, Maria João Cardoso, L.A. Carey, Javier Cortés, Nagi S. El Saghir, Mona Elzayat, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Karen A. Gelmon, Joseph Gligorov, Renate Haidinger, Nadia Harbeck, Xin Hu, Bella Kaufman, Rajneesh Kaur, Belinda E. Kiely, S.-B. Kim, NU Lin, Shirley Mertz, Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer
How much of the research on Gdańsk Medical University is open access?
ScholarIQopen access share
67%OPEN ACCESS